Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 [rekombinantní kvadrivalentní vakcína proti lidskému papilomaviru typu 6, 11, 16, 18]
topical
16
- Terms
-
Gardasil
kvadrivalentní vakcína proti lidským papilomavirům
Silgard
-
Gardasil
HPV L1 Vaccine, Quadrivalent 6,11,16,18
Human Papillomavirus Vaccine L1, Type 6,11,16,18
Human Papillomavirus Vaccine L1, Types 6,11,16,18
Persistent link
https://www.medvik.cz/link/D000068857
Definition
A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from human papillomaviruses of these subtypes.
- DUI
- D000068857 MeSH Browser
- CUI
- M000603960
- History note
- 2016 (2006)
- Public note
- 2016; HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE QUADRIVALENT (TYPES 6, 11, 16, 18) was indexed under PAPILLOMAVIRUS VACCINES 2006-2015
Allowable subheadings
- AD
- administration & dosage 4
- AE
- adverse effects 3
- AG
- agonists
- AA
- analogs & derivatives
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 11
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D20.215.894.815.750
BNT162b5
D20.215.894.899.498.500
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
16